About SAFEHIP®

Hip fractures are the main reason why people are referred to a nursing home. What starts out as an innocent fall may lead to an operation, a long stay in hospital and an increased demand for professional care. In addition, 30% of all people who suffer a hip fracture die within 2 years.¹

In other words, hip fractures are expensive for patients in terms of quality of life, and for society in terms of financial costs.

A growing number of elderly people indicates a future rise in the occurrence of hip fractures. Worldwide, it is estimated that the number of hip fractures will increase from 1.66 million into 2.6 million in 2025 and 6.26 million in 2050.²

SAFEHIP® can help to avoid many of the accidents that lead to a diminished quality of life for many people and to increased treatment and care costs.

TYTEX GROUP started the development of a hip protector in the early nineties in close cooperation with leading experts. The global launch of the first TYTEX GROUP hip protector was a breakthrough leading to the first clinical study on hip protectors. The results were published in the Lancet in 1993. Since then TYTEX GROUP has made research into hip protection a key focus area.




¹) IOF - EFFO Jay magaziner, PhD, MSHyg, Eleanor M. Simonsick, PhD, T. Michael Kashner, PhD, J Richard Hebel, PhD, and John E. Konzona, MD Hvidovre
Symposium Open Bridge 08/2000